Date: 2015-02-05
Type of information: Distribution agreement
Compound: Orion Pharma Animal Health Sedatives product family alpha 2 -agonists and antagonist Dexdomitor®, Domitor® and Domosedan® and Antisedan®
Company: Orion Pharma Animal Health - a part of Orion Corporation (Denmark) Vetoquinol (France)
Therapeutic area: Veterinary medicine
Type agreement: distribution
Action mechanism:
Disease:
Details: * On February 5, 2015, Orion Pharma Animal Health - a part of Orion Corporation - and Vetoquinol announced their collaboration regarding the distribution of Orion Pharma Animal Health Sedatives product family alpha 2 -agonists and antagonist Dexdomitor®, Domitor® and Domosedan® and Antisedan®. Vétoquinol becomes distributor in selected European countries of these Orion Sedative products. The collaboration between the companies is effective as of 1 January 2015 and Vetoquinol is responsible for marketing the sedatives to customers in United Kingdom, Germany, France, Ireland, The Netherlands, Belgium, Luxembourg and Italy. Orion Pharma Animal Health proprietary sedatives range include products Dexdomitor® 0,5 mg/ml, Dexdomitor® 0,1 mg/ml, Domitor®, Antisedan®, Domosedan® and Domosedan Gel®. The Sedative range products are Orion Corporation proprietary products and they belong to the alpha 2 -agonists and antagonist segment. The latest additions to the Orion Pharma Animal Health Sedatives segment are Domosedan Gel® for sublingual dosing on detomidine for horses from year 2010 and Dexdomitor® 0,1 mg/ml for accurate and precise dosing of dexmedetomidine for small sized dogs and cats from year 2012.
Financial terms:
Latest news:
